How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Meridian Bioscience Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
37 clearance records and 22 recall records in the covered releases, across 1 source company names and 25 product codes. Dated history runs from Dec 26, 2002 to Dec 5, 2025.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 2 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 1 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300Z-1019-2026 · OZN | Meridian Bioscience Inc | Recall | Jan 5, 2026FDA classification date |
| Meridian Bioscience, alethia c. Difficile, Catalog Number 480050, Nucleic Acid Amplification Test AssayZ-0568-2026 · OMN | Meridian Bioscience Inc | Recall | Nov 19, 2025FDA classification date |
| Meridian Bioscience, Group B Streptococcus, Catalog Number 480050, Nucleic Acid Amplification Test AssayZ-0569-2026 · NJR | Meridian Bioscience Inc | Recall | Nov 19, 2025FDA classification date |
| RevogeneK243922 · OOI | Meridian Bioscience, Inc. | 510(k) | Mar 20, 2025FDA decision date |
| Para-Pak Clean Vial-For the collection, transportation, preservation, and examination of stool specimens containing intestinal parasites Catalog …Z-0519-2024 · FMH | Meridian Bioscience Inc | Recall | Dec 8, 2023FDA classification date |
| Para-Pak Zn-PVA/10% Formalin-for the routine collection, transportation, preservation, and examination of stool specimens for intestinal parasite…Z-0520-2024 · IGG | Meridian Bioscience Inc | Recall | Dec 8, 2023FDA classification date |
| Cardinal Health Clean Stool Transportation System-For the collection, transportation, preservation, and examination of stool specimens containing…Z-0521-2024 · FMH | Meridian Bioscience Inc | Recall | Dec 8, 2023FDA classification date |
| Premier HpSA Flex (619096)K230901 · LYR | Meridian Bioscience, Inc. | 510(k) | Jul 3, 2023FDA decision date |
| Curian® Shiga ToxinK222829 · GMZ | Meridian Bioscience, Inc. | 510(k) | Apr 17, 2023FDA decision date |
| RevogeneK222779 · OOI | Meridian Bioscience, Inc. | 510(k) | Jan 26, 2023FDA decision date |
| Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700Z-1008-2023 · QJR | Meridian Bioscience Inc | Recall | Jan 20, 2023FDA classification date |
| Revogene, Catalog no. 610210. IVD test instrumentZ-1479-2022 · OOI | Meridian Bioscience Inc | Recall | Jul 28, 2022FDA record creation date |
| RevogeneK220480 · OOI | Meridian Bioscience, Inc. | 510(k) | Jul 11, 2022FDA decision date |
| Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clinical laboratories. Meridian branded Revogene: Catalog Number 610…Z-0836-2022 · OOI | Meridian Bioscience Inc | Recall | Mar 30, 2022FDA record creation date |
| Curian CampyK210976 · LQP | Meridian Bioscience, Inc. | 510(k) | Dec 23, 2021FDA decision date |
| Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on …Z-1540-2021 · QJR | Meridian Bioscience Inc | Recall | May 7, 2021FDA record creation date |
| Revogene RNA Software Upgrade Kit Revogene RNA Software Upgrade USBs Catalog Number: 610240 IVD used to install the Revogene System Software ver…Z-1541-2021 · QJR | Meridian Bioscience Inc | Recall | May 7, 2021FDA record creation date |
| The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum - Product Usage: intended to aid in the diagnosis of recent M…Z-1299-2021 · LJZ | Meridian Bioscience Inc | Recall | Mar 24, 2021FDA record creation date |
| Curian HpSA, Curian AnalyzerK192817 · LYR | Meridian Bioscience, Inc. | 510(k) | Mar 13, 2020FDA decision date |
| PREMIER Cryptococcal Antigen, Catalog Number 602096 Product Usage: The PREMIER Cryptococcal Antigen enzyme immunoassay (EIA) is a screening or …Z-0732-2019 · MDU | Meridian Bioscience Inc | Recall | Jan 14, 2019FDA record creation date |
| PREMIER Platinum HpSA PLUSK182559 · LYR | Meridian Bioscience, Inc. | 510(k) | Nov 5, 2018FDA decision date |
| TRU LegionellaK163273 · MJH | Meridian Bioscience, Inc. | 510(k) | Feb 21, 2017FDA decision date |
| PREMIER EHEC and PREMIER EHEC Bulk.Z-1033-2017 · GNA | Meridian Bioscience Inc | Recall | Jan 17, 2017FDA classification date |
| illumigene Mycoplasma Direct DNA Amplification Assay, illumigene Mycoplasma Direct External Controls, illumipro-10K160829 · OZX | Meridian Bioscience, Inc. | 510(k) | Jun 13, 2016FDA decision date |
| ImmunoCard STAT! HpSAK153661 · LYR | Meridian Bioscience, Inc. | 510(k) | Mar 14, 2016FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.